Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A 32-Week Evaluation.

Int Arch Allergy Immunol · 2026 · PMC12872190 · PMID 41490167

Europe PMC DOI

hedged sentences

0.1180

closest p · 2.4× alpha

0.1180

boldest claim

The sentences

did not reach statistical significancep = 0.118not close (p > 0.1)

Although modest increases were observed in FEF 25–75 values (both absolute and percentage predicted), these changes did not reach statistical significance ( p = 0.118–0.172, respectively).

also in 111,027 other papers

a nonsignificant trendno p-value reported

Forced expiratory flow between 25% and 75% of the FVC (FEF 25–75 ) exhibited a nonsignificant trend toward increase.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.